Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Is it finally time to sell Nvidia ahead of earnings?
Read More
Why Is Moderna (MRNA) Up 6.8% Since Last Earnings Report?
By Zacks Investment ResearchStock MarketsMar 26, 2020 11:30PM ET
www.investing.com/analysis/why-is-moderna-mrna-up-68-since-last-earnings-report-200519694
Why Is Moderna (MRNA) Up 6.8% Since Last Earnings Report?
By Zacks Investment Research | Mar 26, 2020 11:30PM ET A month has gone by since the last earnings report for Moderna (MRNA). Shares have added about 6.8% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Moderna due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Moderna Q4 Earnings Beat Estimates, Revenues Miss
Moderna incurred loss of 37 cents per share in the fourth quarter 2019 compared to loss of $1.14 per share in year-ago period. The Zacks Consensus Estimate was pegged at a loss of 43 cents per share.
Revenues in the quarter were $14.1 million, missing the Zacks Consensus Estimate of $17 million. In the year-ago quarter, revenues were $35.4 million.
Quarter in Details
Collaboration revenue were $10.6 million, down 67.8% year over year. Grant revenues were up 34.4% year over year to $3.5 million.
General and administrative expenses were down 32% to $25.6 million. Research & development expenses decreased 21.1% to $118.8 million due to a decline in licensing and material costs.
The company ended the quarter with $1.26 billion in cash and cash equivalents, compared with $1.34 billion as of Sep 30, 2019.
2020 Guidance Maintained
Moderna maintained its previous guidance for net cash used in operating activities in the range of $490 million - $510 million.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in fresh estimates. The consensus estimate has shifted 7.23% due to these changes.
VGM Scores
At this time, Moderna has a poor Growth Score of F, however its Momentum Score is doing a lot better with a B. However, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of this revision looks promising. It comes with little surprise Moderna has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Moderna, Inc. (MRNA): Free Stock Analysis Report
Original post
Related Articles
NVIDIA Earnings: Can Blackwell Chips Provide Tailwind?
By Dave Kovaleski - Feb 25, 2025
The markets have been sluggish this week as investors hope for a jolt later in the week when AI juggernaut NVIDIA Corporation (NASDAQ:NVDA) reports fourth quarter and year-end...
3 Dividend-Paying Stocks Bucking the Market’s Trend
By Ryan Hasson - Feb 25, 2025
On Friday, a wave of selling pressure swept across the US equity markets, leaving a trail of losses. The S&P 500 closed down 1.7%, the DOW slid 1.69%, and the NASDAQ tumbled a...
Palantir: Down 30% This Week, Is It Time to Flee the High-Flying...
By Alessandro Bergonzi - Feb 25, 2025
6
Palantir remains highly valued with a 460x P/E ratio and a 42.5x P/B ratio, far above its peers. The stock's beta of 2.81 signals high volatility, meaning sharp moves in both...
Why Is Moderna (MRNA) Up 6.8% Since Last Earnings Report?
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.